thesi updat investor hot cold
everyon seem pessimist spring
unexplain shift optim occur fall help
sizeabl repo take stock valuat couldnt make
much sens back level homeostasi
like stock fundament also trend volatil
direct uk feel sieg w/ brexit
reimburs hw disloc profit dont see much
relief ex cost cut contrast us bit better
particularli given specialti mix base case
lsd profit growth dont see risk low
end fy forecast despit increment fx headwind
stefano never miss heard year
estim trend modestli lower dont see hsd
dd grower w/o larg transact see leverag
materi thu share stuck neutral number
slowli come valuat particularli offens
reiter continu prefer outperform rate
upsid risk number compel
valuat easier understand lt strategi tri
mani capit effici thing tough translat
updat forecast pt forecast come
increment fx hw challeng intenational retail partial
off-set incom modest tax benefit forecast
remain consist though modestli st pt
tweak given compress market multipl
risk global retail pharmaci
summari chang
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
manag expect beat bn cost cut initi addit
detail follow post week review
specialti grew quarter impli busi bn
pilot go well far manag contempl
similar hub spoke idea healthcar servic provis
ep beat came line given benefit nci loss
us front end result remain weak given de-emphasi certain product
categori notabl tobacco tough comp though manag appear
undergo rethink front end floor space address
ep guidanc ex-fx reiter fx like provid headwind
vs guidanc first issu
payor
opportun quickli scale program benefit patient
collabor close develop new concept program
connect better consum increas digit capabl
continu invest core system
ocf season work cap invest
half due weak uk market condit
rest except event
sale mostli due
specialti central
rx includ immun
rx growth benefit larg off-set pdp network
last year comp benefit bp hurrican comp
market share quarter bp yoy
gross profit msd yoy
gm reflect continu shift specialti bp
partial off-set procur save
fep lap januari
mostli due
bp tobacco tough year ago comp
hurrican strong cough cold flu season
ex contract manufactur loyalti account
comp uk higher price prior year
expect better perform come quarter
take step improv perform
tradit market declin categori
invest on-line sale low teen
pharmaci healthcar
line in-stor offer
launch new innov brand
modern experi beauti store start top
align cost basi result part global cost program
mm store
constant fx adj ep growth
select store labor invest
share repo ep growth
advers ep impact wors
combin head offic gener purchas
oper effici suppli chain store
boost retail margin promot effect sku
system process recogn custom behavior reduc cost
run busi
half way system invest
track record control sg
restructur chile mexico alreadi address margin
program address less month
program small show agil address cost
improv warehous network etc select market
save mm per annum
undertak global review cost basi
start global smart spend zero base budget
digit enterpris enhanc enterpris lower cost
target excess cost save end year
still valid market respons partnership kc
may provid templat primari care mani store
continu build labcorp patient servic center
expand relationship alibaba alipay us store
stronger posit brand mass pharmacy-l health
focu new product store beauti experi
store end februari
asian custom buy tmall alipay us store
announc program intent
part confidenti
good grasp mexico chile wholes
took charg
irr
accentur assist
initi estim potenti size
first part program includ warehous consolid store
cost reduc travel/consult
optizim requir month sever
comfort around bn number expect exceed
end larg degre transpar
week confirm size target
step digit compani
piec come togeth quickli
tough estim
least usual come non-peopl cost
reaction custom key focus senior
conveni factor obviou
connect pharmacist health care profession
atmospher becom healthcar vs conveni
look forward think across us could number
locat hub spoke idea
great properti dont popul support
front end although support pharmaci could transform
space healthcar
op ep
reinvest us busi bp total corpor
unusu event
sold boot contract manufactur restat
chang loyalti program account uk
two item almost bp
less perturb growth cycl odd
look prior year pace oper incom
stronger weaker
feel good year weak comp
growth platform
comfort full year guid despit result
almost everi store
growth substanti number peopl drop off/pick
prefer non-pref aetna
work prefer relationship cigna
store
thousand store start see contribut
contribut billion signific
increment contribut partnership
stronger contribut refer primarili adjust oper incom
medexpress partnership
wait see perform
perform roughli expect
valuat methodolog base mix discount cash flow analysi rel valuat multipl
downsid risk potenti on-line competit amazon erod front end comp margin us
pharmaci share continu reimburs pressur us eu hit ultim lead total margin compress
transact prove challeng increas volum /revenu store appear futil lead poor return
posit independ retail us becom disadvantag vertic integr peer capabl take notabl
share manag unabl locat creativ transact leav balanc sheet underutil limit total oper
growth beauti push ultim becom distract momentum build manag must revisit costli rebuild
laboratori corp america
articl articl
time dissemin decemb
analyst elizabeth anderson suzi yoon ross muken primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
